ID   TOV-3041G
AC   CVCL_9T24
SY   TOV3041G
DR   CancerTools; 161780
DR   Wikidata; Q54972813
RX   PubMed=26622941;
CC   Doubling time: 1.33 +- 0.02 days (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,11
ST   D21S11: 29
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
RX   PubMed=26622941; DOI=10.18632/genesandcancer.76; PMCID=PMC4633166;
RA   Fleury H., Communal L., Carmona E., Portelance L., Arcand S.L.,
RA   Rahimi K., Tonin P.N., Provencher D.M., Mes-Masson A.-M.;
RT   "Novel high-grade serous epithelial ovarian cancer cell lines that
RT   reflect the molecular diversity of both the sporadic and hereditary
RT   disease.";
RL   Genes Cancer 6:378-398(2015).
//